Zur Rose AG logo

ROSE - Zur Rose AG Share Price

CHF193 6.2  3.3%

Last Trade - 29/05/20

Sector
Consumer Defensives
Size
Mid Cap
Market Cap £1.51bn
Enterprise Value £1.70bn
Revenue £1.14bn
Position in Universe 304th / 1052
Bullish
Bearish
Unlock ROSE Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Financial Summary
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2019, Zur Rose Group AG revenues increased 12% to SF1.36B. Net loss increased 34% to SF52.4M. Revenues reflect Germany segment increase of 14% to SF762.8M, Switzerland segment increase of 5% to SF553M. Higher net loss reflects Office and administrative expenses increase from SF24.9M to SF76.8M (expense), Marketing and acquisition expenses increase of 29% to SF53.2M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ROSE Revenue Unlock ROSE Revenue

Net Income

ROSE Net Income Unlock ROSE Revenue

Normalised EPS

ROSE Normalised EPS Unlock ROSE Revenue

PE Ratio Range

ROSE PE Ratio Range Unlock ROSE Revenue

Dividend Yield Range

ROSE Dividend Yield Range Unlock ROSE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ROSE EPS Forecasts Unlock ROSE Revenue
Profile Summary

Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.

Directors
Last Annual December 31st, 2019
Last Interim December 31st, 2019
Incorporated April 6, 1993
Public Since July 6, 2017
No. of Shareholders: 6,350
No. of Employees: 1,710
Sector Consumer Defensives
Industry Food & Drug Retailing
Index
Exchange SIX Swiss Exchange
Shares in Issue 9,582,097
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ROSE Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ROSE
Upcoming Events for ROSE
Frequently Asked Questions for Zur Rose AG
What is the Zur Rose AG share price?

As of 29/05/20, shares in Zur Rose AG are trading at CHF193, giving the company a market capitalisation of £1.51bn. This share price information is delayed by 15 minutes.

How has the Zur Rose AG share price performed this year?

Shares in Zur Rose AG are currently trading at CHF193 and the price has moved by 90.03% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Zur Rose AG price has moved by 0.104k% over the past year.

What are the analyst and broker recommendations for Zur Rose AG?

Of the analysts with advisory recommendations for Zur Rose AG, there are there are currently 1 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Zur Rose AG is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Zur Rose AG next release its financial results?

Zur Rose AG is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the Zur Rose AG dividend yield?

Zur Rose AG does not currently pay a dividend.

Does Zur Rose AG pay a dividend?

Zur Rose AG does not currently pay a dividend.

When does Zur Rose AG next pay dividends?

Zur Rose AG does not currently pay a dividend.

How do I buy Zur Rose AG shares?

To buy shares in Zur Rose AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Zur Rose AG?

Shares in Zur Rose AG are currently trading at CHF193, giving the company a market capitalisation of £1.51bn.

Where are Zur Rose AG shares listed? Where are Zur Rose AG shares listed?

Here are the trading details for Zur Rose AG:

Country of listing: Switzerland
Exchange: SWX
Ticker Symbol: ROSE
What kind of share is Zur Rose AG?

Based on an overall assessment of its quality, value and momentum, Zur Rose AG is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Zur Rose AG share price forecast 2020?

Shares in Zur Rose AG are currently priced at CHF193. At that level they are trading at 19.5% premium to the analyst consensus target price of 0.00.

Analysts covering Zur Rose AG currently have a consensus Earnings Per Share (EPS) forecast of -5.411 for the next financial year.

How can I tell whether the Zur Rose AG share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zur Rose AG. Over the past six months, the relative strength of its shares against the market has been 0.127k%. At the current price of CHF193, shares in Zur Rose AG are trading at 62.98% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Zur Rose AG PE Ratio?

We were not able to find PE ratio data for Zur Rose AG.

Who are the key directors of Zur Rose AG?

Zur Rose AG's management team is headed by:

Walter Oberhaensli - CMG
Marcel Ziwica - CFO
Thomas Schneider - NVC
Walter Hess - MGB
Stefan Feuerstein - NEC
Olaf Heinrich - MGB
Tobias Hartmann - NED
Christian Mielsch - NED
Volker Amelung - NED
Bernd Gschaider - COO
David Maso - MGB
Betul Unaran - MGB
Who are the major shareholders of Zur Rose AG?

Here are the top five shareholders of Zur Rose AG based on the size of their shareholding:

KWE Beteiligungen AG Corporation
Percentage owned: 9.73% (938k shares)
UBS Asset Management (Switzerland) Investment Advisor
Percentage owned: 6.62% (638k shares)
T. Rowe Price International (UK) Ltd. Investment Advisor/Hedge Fund
Percentage owned: 4.47% (431k shares)
Credit Suisse Asset Management Investment Advisor/Hedge Fund
Percentage owned: 4.45% (429k shares)
Al Faisaliah Group Holding Company
Percentage owned: 4.14% (399k shares)
Similar to ROSE
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.